Načítá se...
Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: A Malaysian experience
Over the years, allopurinol has been widely used as the preferred choice of urate lowering therapy in patients with gout. However, its role in patients with renal impairment is limited; and adverse reactions are well documented. Febuxostat, a newer oral non-purine xanthine oxidase inhibitor has been...
Uloženo v:
| Vydáno v: | SAGE Open Med Case Rep |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5753890/ https://ncbi.nlm.nih.gov/pubmed/29318019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X17749080 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|